PEROTTI, Paola Carla Giuseppina
Dettaglio
PEROTTI, Paola Carla Giuseppina
SCIENZE CLINICHE E BIOLOGICHE
Pubblicazioni
Risultati 1 - 20 di 33 (tempo di esecuzione: 0.001 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. | 2015 | Ardito, A; Massaglia, C; Pelosi, E; Zaggia, B; Basile, V; Brambilla, R; Vigna-Taglianti, F; Duregon, E; Arena, V; Perotti, P; Penna, D; Terzolo, M. |
2 | Activity and safety of temozolomide in advanced adrenocortical carcinoma patients | 2019 | Cosentini, Deborah; Badalamenti, Giuseppe; Grisanti, Salvatore; Basile, Vittoria; Rapa, Ida; Cerri, Sara; Spallanzani, Andrea; Perotti, Paola; Musso, Emanuela; Laganà, Marta; Ferrari, Vittorio; Luppi, Gabriele; Dalla Volta, Alberto; Incorvaia, Lorena; Sigala, Sandra; Russo, Antonio; Volante, Marco; Terzolo, Massimo; Berruti, Alfredo |
3 | Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. | 2018 | Claps, Melanie; Cerri, Sara; Grisanti, Salvatore; Lazzari, Barbara; Ferrari, Vittorio; Roca, Elisa; Perotti, Paola; Terzolo, Massimo; Sigala, Sandra; Berruti, Alfredo |
4 | Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. | 2019 | Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M. |
5 | Adrenocortical Carcinoma with Hypercortisolism. | 2018 | Puglisi S, Perotti P, Pia A, Reimondo G, Terzolo M. |
6 | Aluminium blunts the proliferative response and increases apoptosis of cultured human cells: putative relationship to alzheimer's disease | 2007 | PROLO P; CHIAPPELLI F; GRASSO E; ROSSO MG; NEAGOS N; DOVIO A; SARTORI ML; PEROTTI P; FANTÒ F; CIVITA M; FIORUCCI A; VILLANUEVA P; ANGELI A |
7 | Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas | 2016 | Reimondo, Giuseppe; Chiodini, Iacopo; Puglisi, Soraya; Pia, Anna; Morelli, Valentina; Kastelan, Darko; Cannavo, Salvatore; Berchialla, Paola; Giachino, Daniela; Perotti, Paola; Cuccurullo, Alessandra; Paccotti, Piero; Beck-Peccoz, Paolo; Marchi, Mario De; Terzolo, Massimo |
8 | Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome | 2008 | A. Berruti; F. Vana; M. Tucci; A. Mosca; L. Russo; G. Gorzegno; A. Saini; P. Perotti; M. Tampellini; L. Dogliotti |
9 | Chemotherapy | 2011 | Alfredo Berruti; Paola Sperone; Paola Perotti; Anna Ferrero; Luigi Dogliotti; and Massimo Terzolo |
10 | A current perspective on treatment of adrenocortical carcinoma | 2014 | Massimo Terzolo, Silvia De Francia, Arianna Ardito, Paola Perotti, Laura Ferrari, Alfredo Berruti |
11 | CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells | 2018 | Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo* |
12 | Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. | 2018 | Puglisi S, Perotti P, Cosentini D, Roca E, Basile V, Berruti A, Terzolo M. |
13 | Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients | 2019 | Puglisi S, Pizzuto A, Laface B, Panero F, Aprà F, Palmas E, Perotti P, Reimondo G, Boccuzzi A, Terzolo M |
14 | Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines | 2009 | Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A. |
15 | Differential patterns of glucocorticoid receptors and 11beta hydroxysteroid dehydrogenase activity in androgen-dependent and androgen-independent prostate cancer cell lines. Relevance to glucocorticoid sensitivity. | 2007 | Dovio A; Sartori ML; Perotti P; Abbadessa G; De Francia S; Bianco E; Racca S; Angeli A. |
16 | Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma | 2017 | Reimondo, Giuseppe Matteo; Puglisi, Soraya; Zaggia, Barbara; Basile, Vittoria; Saba, Laura; Perotti, Paola Carla Giuseppina; DE FRANCIA, Silvia; Volante, Marco; Maria Chiara Zatelli, ; Salvatore, Cannavò; Terzolo, Massimo |
17 | Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) | 2009 | DAFFARA Fulvia Claudia, ; DE FRANCIA SILVIA, ; Ardito, Arianna; Zaggia, Barbara; Fiori, C.; Angeli, Alberto; SCARPA Roberto Mario, ; Porpiglia, Francesco; Perotti, P.; Berruti, Alfredo; Terzolo, Massimo |
18 | Gemcitabine-based chemotherapy in adrenocortical carcinoma: A multicenter study of efficacy and predictive factors | 2017 | Henning J.E.K.; Deutschbein T.; Altieri B.; Steinhauer S.; Kircher S.; Sbiera S.; Wild V.; Schlotelburg W.; Kroiss M.; Perotti P.; Rosenwald A.; Berruti A.; Fassnacht M.; Ronchi C.L. |
19 | Immunotherapy failure in adrenocortical cancer: Where next? | 2018 | Cosentini D.; Grisanti S.; Volta A.D.; Lagana M.; Fiorentini C.; Perotti P.; Sigala S.; Berruti A. |
20 | Metronomic therapy concepts in the management of adrenocortical carcinoma. | 2011 | Berruti A; Sperone P; Bellini E; Daffara F; Perotti P; Ardito A; Saini A; Terzolo M. |